Target Information
| Target General Infomation | |||||
|---|---|---|---|---|---|
| Target ID |
T03755
|
||||
| Former ID |
TTDC00244
|
||||
| Target Name |
Bcl-2-like protein 2
|
||||
| Gene Name |
BCL2L2
|
||||
| Synonyms |
Apoptosis regulator Bcl-W; Bcl2-L-2; BCL2L2
|
||||
| Target Type |
Clinical Trial
|
||||
| Disease | Advanced small cell lung cancer; Relapsed or refractory chronic lymphocytic leukemia; Lymphoid malignancies [ICD9: 140-229, 140-239, 162, 162.9, 202, 204.0, 204.1, 208.9; ICD10: C33-C34, C34.90, C81-C86, C91-C95, C91.0, C91.1] | ||||
| Function |
Promotes cell survival. Blocks dexamethasone-induced apoptosis. Mediates survival of postmitotic Sertoli cells by suppressing death-promoting activity of BAX.
|
||||
| BioChemical Class |
Bcl-2 family
|
||||
| Target Validation |
T03755
|
||||
| UniProt ID | |||||
| Sequence |
MATPASAPDTRALVADFVGYKLRQKGYVCGAGPGEGPAADPLHQAMRAAGDEFETRFRRT
FSDLAAQLHVTPGSAQQRFTQVSDELFQGGPNWGRLVAFFVFGAALCAESVNKEMEPLVG QVQEWMVAYLETQLADWIHSSGGWAEFTALYGDGALEEARRLREGNWASVRTVLTGAVAL GALVTVGAFFASK |
||||
| Drugs and Mode of Action | |||||
| Target Expression Profile (TEP) and Drug Resistance Mutation (DRM) | |||||
| TEP | EXP Info | ||||
| Pathways | |||||
| KEGG Pathway | MicroRNAs in cancer | ||||
| PANTHER Pathway | Apoptosis signaling pathway | ||||
| Pathway Interaction Database | Direct p53 effectors | ||||
| WikiPathways | Apoptosis | ||||
| Apoptosis Modulation and Signaling | |||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Tang and Dr. Zhang.